TracerDX is the operator of an ultrasensitive Circulating tumor DNA (ctDNA) assay center intended for longitudinal molecular response monitoring
TracerDX is the operator of an ultrasensitive Circulating tumor DNA (ctDNA) assay center intended for longitudinal molecular response monitoring. The company's technology focuses on real-time visualization of detailed anatomy during surgery, specifically highlighting all nerves in the body administered intravenously and integrated into existing clinical imaging systems, thereby enabling patients to receive effective treatment while preventing damage and enhancing patient outcomes.